SEC Form 4 · accession 0001104659-16-127493
Aralez Pharmaceuticals Inc. · ARLZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
francis martin thrasher
Director
Period of report
Jun 13, 2016
Accepted (ET)
Jun 15, 2016 · 9:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001660719
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par valueF1 | Jun 13, 2016 | M | 4,365 | $2.82 | A | 277,178 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1,F2 | $2.82 | Jun 13, 2016 | M | 4,365 | D | — | Jun 22, 2016 | Common Shares, without par value | 4,365 | 0 | D |
Explanation of responses
- F1Price is presented in Canadian dollars.
- F2The option was exercisable as of the Reporting Person's previous filing on Form 3, dated as of February 8, 2016.